News & Analysis as of August 17, 2025

Capital Markets

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

Will Labour’s policy prescription create a stronger UK life sciences sector?

A&O Shearman on 3/27/2025

The UK government plans to turbocharge the life sciences sector using policy levers to enhance research and development, innovation hubs, and private fundraising. In this piece, Michael Bloch explores how refinements to...more

Biotech Public Markets Finally Thawing(?): Two Massachusetts Biotechs file S-1s

Foley Hoag LLP - Public Companies & the Law on 8/26/2024

In an encouraging sign that the equity capital markets may be improving for biotechnology companies, Bicara Therapeutics Inc. and Zenas Biopharma, Inc. filed S-1 registration statements yesterday, signaling their intention to...more

Healthcare Trends & Transactions Q2 2023

Bass, Berry & Sims PLC on 7/28/2023

The healthcare M&A market appears to be steadying. Although deal activity through the year appears slightly below the high-water marks for the corresponding period of 2022, deal activity is generally up from the first quarter...more

2022 Technology and Life Sciences PIPE Report

Wilson Sonsini Goodrich & Rosati on 4/27/2023

In this inaugural issue of the 2022 Technology and Life Sciences PIPE Report, we present analysis related to 108 private investments in public equity (PIPEs) by U.S.-based technology and life sciences companies between...more

Report on Hong Kong-Listed Biotech Companies - April 2023

Skadden, Arps, Slate, Meagher & Flom LLP on 4/25/2023

点击此处阅读调查报告全文 Our third annual report on Hong Kong-listed biotech companies examines how the sector performed during the challenging conditions for capital markets globally over the past 12 months. Although aggregate listing...more

Life Sciences IPO Summit: Insurance and Factors That Impact IPO

Woodruff Sawyer on 1/4/2022

Experts from the life sciences industry shared their insights on the steps to going public in a virtual summit hosted by Woodruff Sawyer. The Summit featured leaders representing Cooley, the New York Stock Exchange (NYSE),...more

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2021

Orrick, Herrington & Sutcliffe LLP on 7/22/2021

This edition of Orrick’s life sciences publication series reviews the key drivers of venture investment in the life sciences industry, which is proceeding at a record pace thus far in 2021. Key findings include: Investment...more

Coronavirus/COVID-19 Update

Skadden, Arps, Slate, Meagher & Flom LLP on 3/5/2020

As health organizations and governments around the world work to contain the coronavirus (COVID-19), businesses should be mindful of the various ways the virus may impact their operations and employees. The wide range of...more

To IPO, Or Not to IPO, That Is the Question - How to prepare for and execute a successful public offering

Troutman Pepper Locke on 2/8/2019

More than ever, life sciences companies are going public to raise capital for future growth. In fact, U.S. equity financing in life sciences skyrocketed to a record $7 billion in 2018—a 69 percent jump over the year before. ...more

9 Results

View per page

Page: of 1

Today's Popular Updates › Life Sciences › Capital Markets

"My best business intelligence, in one easy email…"